Sitagliptin
Sitagliptin is a pharmaceutical drug with 289 clinical trials. Currently 9 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 217 completed trials
Phase Distribution
Phase Distribution
28
Early Stage
43
Mid Stage
177
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.5%
217 of 251 finished
13.5%
34 ended early
9
trials recruiting
289
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Clinical Trials (289)
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Anti-Diabetic Medications to Fight PD and LBD
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
HbA1c Variability in Type II Diabetes
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 289